Used to measure the activity of the SETDB2 enzyme in human samples, this ELISA kit supports research in epigenetics, particularly in studies related to histone methylation. It enables scientists to quantify changes in SETDB2 levels in response to diseases such as cancer, autoimmune disorders, and viral infections. The kit is valuable in drug development for assessing the impact of therapeutic compounds on epigenetic regulation. It is also applied in basic research to understand gene silencing mechanisms and chromatin dynamics in human cells.